FDA approves birch triterpenes gel as topical medication for epidermolysis bullosa Dr. Kamal Kant Kohli20 Dec 2023 5:30 PM ISTThe US Food and Drug Administration (FDA) has approved the new birch triterpenes topical gel (Filsuvez) for treating 2 variants of epidermolysis...
FDA approves topical gene therapy for treating blistering wounds in dystrophic epidermolysis bullosa Dr. Kamal Kant Kohli20 May 2023 9:00 AM ISTThe US food and drug administration has approved herpes-simplex virus type 1 vector-based gene therapy, Vyjuvek for dystrophic epidermolysis bullosa...
Topical gene therapy promising for complete wound healing in dystrophic epidermolysis bullosa patients: NEJM Medha Baranwal15 Dec 2022 8:00 PM ISTUSA: Dystrophic epidermolysis bullosa is a genetic skin disorder that causes the skin to be fragile and blister easily. Mutations in COL7A1 that...
